Form 8-K UNITED THERAPEUTICS Corp For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
United Therapeutics Corp. (UTHR) PT Raised to $344 at Ladenburg Thalmann
October 31, 2024 7:04 AM EDTLadenburg Thalmann analyst Matthew Kaplan raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $344.00 (from $319.00) while maintaining a Neutral rating.
The analyst comments "3Q24 results. Total revenues for 3Q24 were $748.9 million, higher than our estimate of $746.5 million. The revenue increase in 3Q24 ($748.9... More
